APA (7th ed.) Citation

K, B., P, K., C, K., T, M., SJ, A., & EI, O. (2025). A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. Cancers, 17(11), . https://doi.org/10.3390/cancers17111829

Chicago Style (17th ed.) Citation

K, Burcher, Karukonda P, Kelsey C, Mullikin T, Antonia SJ, and Oduah EI. "A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC." Cancers 17, no. 11 (2025). https://doi.org/10.3390/cancers17111829.

MLA (9th ed.) Citation

K, Burcher, et al. "A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC." Cancers, vol. 17, no. 11, 2025, https://doi.org/10.3390/cancers17111829.